Promakhos Therapeutics Inc, based in Somerville, MA, is a biotech company founded in 2021 that focuses on developing curative therapies for chronic inflammatory diseases. Their innovative approach aims to restore the balance and function of the immune system, allowing the body to control inflammation and promote healing. Led by a team of distinguished scientists and entrepreneurs, Promakhos Therapeutics is dedicated to addressing the root causes of diseases such as Crohn's disease, multiple sclerosis, and ankylosing spondylitis, rather than simply treating symptoms.
With expertise in immunology, protein secretion, biochemistry, and cell biology, the team at Promakhos Therapeutics is committed to advancing translational research and developing novel immunomodulatory therapeutics. Their CEO and President, Katerina Chatzi, Ph.D., has over 15 years of experience in biomedical research, uncovering fundamental principles underlying bacterial secretion, protein folding, antibiotic resistance, and cell cycle regulation. Together with Chief Scientific Officer Jasper E. Neggers, Ph.D., who has a background in microbiology, immunology, and drug discovery, Promakhos Therapeutics is poised to make significant contributions in the field of chronic inflammatory diseases.
Generated from the website